Jinxin Fertility Group Limited (JXR) filed its Monthly Return with the Hong Kong Stock Exchange for the period ended 31 March 2026, confirming a stable capital structure and full compliance with public-float requirements.

Authorised Capital • The authorised share capital remained unchanged at 5.00 billion ordinary shares with a par value of USD 0.00001, equivalent to total authorised capital of USD 50,000.

Issued and Treasury Shares • Issued shares (excluding treasury shares): 2.74 billion. • Treasury shares: 13.00 million. • Total issued shares: 2.76 billion. • No shares were issued, cancelled, or transferred during the month, and the company confirmed that the public float stayed above the 25 % threshold stipulated by HKEX rules.

Repurchase Activity Awaiting Cancellation • Between 5 December 2025 and 31 March 2026, JXR repurchased 45.97 million shares that have not yet been cancelled as of the statement date. No additional repurchases occurred in March 2026.

Equity Incentive Scheme • Under the 2025 Share Scheme approved on 5 December 2025, the board previously granted rights covering up to 140.84 million ordinary shares. No new shares were issued or treasury shares transferred in March 2026 pursuant to this scheme.

Regulatory Compliance • The company’s Chief Executive Officer, Acting Chief Financial Officer and Executive Director, Mr. Dong Yang, certified that all activities were duly authorised and compliant with HKEX listing rules and applicable regulations.